Add to my selection

NEURACEQ (florbétabène (18F))

Medicine - Posted on Apr 25 2023

Active substance (DCI)

florbétabène (18F)

history (2)

4/4/23

NEURACEQ (florbetaben 18F) - Alzheimer’s Disease

First assessment. Key points Favourable opinion on reimbursement for Positron Emission Tomography (PET) imaging in the diagn...

CAV :
54321

icône flèche
1/9/19

NEURACEQ (florbétabène (18F))

Intérêt clinique insuffisant pour justifier son remboursement dans la détection des plaques séniles β amyloïdes en raison de...

icône flèche

Technical information

ATC code

V09AX06

Manufacturer

CURIUM PET FRANCE

Presentation

NEURACEQ 300 MBq/mL solution injectable
1 flacon en verre (CIP : 34009 586 825 2 0)

All our publications

Alzheimer’s disease and mental disorders

Central nervous system diseases

Medical imaging

Neurodegenerative diseases